Bibliographie (2546)
Ensuring adequate palliative and hospice care during COVID-19 surges
mardi, 22 septembre 2020 12:40 Écrit par Zouhair SouissiEnsuring Adequate Palliative and Hospice Care During COVID-19 Surges – JAMA Commentary on Twitter An ethical approach to #pandemic surge planning requires providing for patients seeking symptom relief & comfort at the end of life. Not to do so undermines patient, family trust, emotional health, and core values of society https://t.co/P0LeYuZwzt @MatthewWynia @CUPallCare — […]
The post Ensuring adequate palliative and hospice care during COVID-19 surges appeared first on Links Medicus.
What can we expect from first-generation COVID-19 vaccines?
mardi, 22 septembre 2020 12:40 Écrit par Zouhair SouissiWhat can we expect from first-generation COVID-19 vaccines? – The Lancet Commentary on Twitter We need to calibrate our expectations for the 1st generation of #SARSCoV2 vaccines https://t.co/QTJbyOd9xQ @TheLancet by @gmleunghku and Malik Peiris @hkumed Pe-covid normalcy is not near. pic.twitter.com/Y15TqfoRlf — Eric Topol (@EricTopol) September 21, 2020
The post What can we expect from first-generation COVID-19 vaccines? appeared first on Links Medicus.
![[ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer](/media/k2/items/cache/d4b22e8d4b1fb6349c7d95bc5629e3c0_M.jpg)
[ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer
mardi, 22 septembre 2020 11:29 Écrit par Zouhair SouissiNo benefit for post-operative radiotherapy in non-small-cell lung cancer – European Society of Medical Oncology Commentary: Phase 3 Trial Results Do Not Support PORT in Resected Stage IIIAN2 NSCLC – Targeted Oncology
The post [ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer appeared first on Links Medicus.
![[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials](/media/k2/items/cache/9f9f79e544fb8eb705d18df3c18b9f0a_M.jpg)
[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials
lundi, 21 septembre 2020 00:38 Écrit par Zouhair SouissiMortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials – medRxiv Commentary on Twitter This meta-analysis of 7,913 patients from 26 RCTs (16 unpublished) found no mortality benefit to #hydroxychloroquine or chloroquine in COVID19 Combined summary OR for all-cause mortality for HCQ 1.08, 95%CI 0.99-1.18 Confirms HCQ does […]
The post [Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials appeared first on Links Medicus.
Decreased influenza activity during the COVID-19 pandemic
lundi, 21 septembre 2020 00:38 Écrit par Zouhair SouissiDecreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020 – CDC Morbidity and Mortality Weekly Report Commentary: COVID-19 prevention might translate into – MedicalXpress
The post Decreased influenza activity during the COVID-19 pandemic appeared first on Links Medicus.
Severe COVID-19 infections—knowledge gained and remaining questions
lundi, 21 septembre 2020 00:38 Écrit par Zouhair SouissiSevere COVID-19 Infections—Knowledge Gained and Remaining Questions – JAMA Internal Medicine Commentary on Twitter Just out @JAMAInternalMed – our editorial on what we've learned about severe #Covid19 pneumonia so far and what challenges are still ahead. Honored and proud to have written this together with Carolyn Calfee and Dan Brodie. https://t.co/rmVjUWNyvM — Lieuwe Bos […]
The post Severe COVID-19 infections—knowledge gained and remaining questions appeared first on Links Medicus.
Editorial: Convalescent plasma for Covid-19
dimanche, 20 septembre 2020 23:35 Écrit par Zouhair SouissiConvalescent plasma for covid-19 – The BMJ Commentary on Twitter Last month the US FDA authorised the emergency use of convalescent plasma for hospital patients with covid-19. What evidence underpinned the FDA’s controversial decision? And will the authorisation make it more difficult to recruit participants for RCTS? https://t.co/PMO13J2IOq — The BMJ (@bmj_latest) September 19, […]
The post Editorial: Convalescent plasma for Covid-19 appeared first on Links Medicus.
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19
dimanche, 20 septembre 2020 23:35 Écrit par Zouhair SouissiComparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations – Critical Care
The post Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19 appeared first on Links Medicus.
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
vendredi, 18 septembre 2020 12:07 Écrit par Zouhair SouissiClustering and superspreading potential of SARS-CoV-2 infections in Hong Kong – Nature Medicine Commentary: Superspreaders of SARS-CoV-2 – Virology Blog Commentaries on Twitter Cases linked to #superspreading events are estimated to account for 80% of all local transmission of #SARSCoV2 in Hong Kong in a study with implications for public health policies. @bencowling88 @gmleunghku […]
The post Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong appeared first on Links Medicus.
The pooled prevalence of pulmonary embolism in patients with COVID-19
vendredi, 18 septembre 2020 12:07 Écrit par Zouhair SouissiThe pooled prevalence of pulmonary embolism in patients with COVID-19 – Intensive Care Medicine Commentary on Twitter Pulmonary embolism in #COVID19, be careful! quantitative meta-analysis ->pooled prevalence in pts undergoing #PE diagnosis 28%higher pooled prevalence in pts admitted to #ICU vs those admitted to non-ICU: 19 vs 9%Open access @yourICM #COVIDFOAM #FOAMcc https://t.co/dUqKAVoeCV pic.twitter.com/fvmQnTlv1M […]
The post The pooled prevalence of pulmonary embolism in patients with COVID-19 appeared first on Links Medicus.
